Christopher Willett, MD - Duke Medicine

Leadership Chancellor Administration Victor J. Dzau, MD R. Sanders Williams, MD Nancy Andrews, MD, PhD Catherine Lynch Gilliss, DNSc Asif Ahmad Monte D. Brown, MD Robert M. Califf, MD Michael Cuffe, MD Karen Frush, MD Mary Ann Fuchs, RN William J. Fulkerson Jr., MD Ranga R. Krishnan, MB ChB Kenneth C. Morris Michael J. Morsberger Paul Newman Molly O'Neill Robert L. Taber, PhD Douglas B. Vinsel Kerry Watson Huntington F. Willard, PhD Mark Newman, MD Kenneth Kreuzer, PhD Elizabeth DeLong, PhD Brigid Hogan, PhD J. Lloyd Michener, MD Thomas F. Tedder, PhD Harvey Jay Cohen, MD Thomas Petes, PhD James McNamara, MD Haywood Brown, MD David L. Epstein, MD Salvatore Pizzo, MD, PhD Joseph St. Geme III, MD Anthony R. Means, PhD Ranga R. Krishnan, MB ChB Christopher Willett, MD Carl E. Ravin, MD Danny O. Jacobs, MD Board Members
	Home > Leadership > Administration > Christopher Willett, MD Christopher Willett, MD Christopher G. Willett, MD, a nationally renowned specialist in gastrointestinal cancers, is the chair of Department of Radiation Oncology at Duke University Medical Center. Willett came to Duke in 2004 from the Boston area, where he served as clinical director of radiation oncology at Massachusetts General Hospital and as a professor of radiation oncology at Harvard Medical School. He received his undergraduate and medical degrees from Tufts University in Boston followed by a surgical internship at Vanderbilt University Medical Center in Nashville and a residency in radiation medicine at Massachusetts General Hospital. He joined the faculty at Harvard in 1986, and also has held appointments as a radiation oncologist at Brigham and Women’s Hospital and the Dana-Farber Cancer Center in Boston. The author of more than 150 scientific papers and reviews, Willett also has authored book chapters on intraoperative irradiation and gastrointestinal cancer. He has served as the president of the International Society of Intraoperative Radiation Therapy, a group he helped found in 1996, and as chairman of the GI Committee of the Radiation Therapy Oncology Group, a national cooperative conducting clinical trials in cancer.